Get the Stockscreener App
1.54
20.31%
0.26
Pre-market:
1.54
Standard Biotools Inc stock is traded at $1.54, with a volume of 4.60M.
It is up +20.31% in the last 24 hours and up +5.48% over the past month.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
See More
Previous Close:
$1.28
Open:
$1.39
24h Volume:
4.60M
Relative Volume:
2.59
Market Cap:
$592.23M
Revenue:
$106.34M
Net Income/Loss:
$-74.66M
P/E Ratio:
-1.6211
EPS:
-0.95
Net Cash Flow:
$-46.12M
1W Performance:
+20.31%
1M Performance:
+5.48%
6M Performance:
+18.46%
1Y Performance:
-12.00%
1-Day Range:
$1.375
$1.57
1-Week Range:
$1.235
$1.57
52-Week Range:
$0.92
$2.14
Standard Biotools Inc Stock (LAB) Company Profile
Name
Standard Biotools Inc
Sector
Industry
Phone
(650) 266-6000
Address
2 TOWER PLACE, SOUTH SAN FRANCISCO
Compare LAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.54 | 492.24M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
126.18 | 220.91B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.38 | 146.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.21 | 140.64B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.69 | 127.91B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.58 | 49.23B | 5.88B | 1.34B | 799.60M | 2.3489 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-27-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-24 | Initiated | TD Cowen | Buy |
| Apr-04-24 | Initiated | Jefferies | Buy |
| Jul-12-23 | Initiated | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Stock (LAB) Latest News
Can Standard BioTools Inc. stock maintain operating marginsLayoff News & Expert-Curated Trade Recommendations - ulpravda.ru
Will Standard BioTools Inc. (FLB) stock rise with strong economyJuly 2025 Catalysts & Low Risk High Reward Ideas - ulpravda.ru
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue - Investing News Network
Standard BioTools Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2025 - MarketScreener
Standard BioTools Reports Preliminary Q4, Full-Year Revenue - Nasdaq
Standard BioTools (NASDAQ:LAB) & Hinge Health (NYSE:HNGE) Critical Contrast - Defense World
What analysts say about Standard BioTools Inc stockExit Strategy Tips & Investment Portfolio Recommendations - earlytimes.in
User | theeveningleader.comStandard BioTools Inc.Common Stock (Nasdaq:LAB) Stock Quote - markets.financialcontent.com
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 80% - simplywall.st
Standard BioTools: Outlook Still Murky (NASDAQ:LAB) - Seeking Alpha
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% – Here’s Why - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1%What's Next? - MarketBeat
What Standard BioTools Inc.'s (NASDAQ:LAB) 28% Share Price Gain Is Not Telling You - 富途牛牛
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9% – What’s Next? - Defense World
Can Standard BioTools Inc. stock sustain market leadershipWeekly Profit Summary & Detailed Earnings Play Alerts - Улправда
Is Standard BioTools Inc. stock a buy before product launchesQuarterly Portfolio Report & AI Powered Trade Plan Recommendations - bolumsonucanavari.com
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9%Time to Sell? - MarketBeat
Is Standard BioTools Inc. stock a top pick in earnings seasonIndex Update & Reliable Intraday Trade Alerts - Bölüm Sonu Canavarı
Is Standard BioTools Inc. (FLB) stock bottoming after sell offWeekly Loss Report & Low Volatility Stock Suggestions - Улправда
Will Standard BioTools Inc. stock outperform growth indexesBreakout Watch & Expert Verified Movement Alerts - Улправда
Is Standard BioTools Inc. stock a safe investment in uncertain markets2025 Buyback Activity & Safe Entry Zone Tips - ulpravda.ru
Will Standard BioTools Inc. stock benefit from green energy trendsGDP Growth & Trade Opportunity Analysis - Улправда
Analysts Set Standard BioTools Inc. (NASDAQ:LAB) Price Target at $1.35 - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Zacks Research - MarketBeat
Get in on Standard BioTools Inc’s (LAB) buy-in window today! - setenews.com
Should investors be concerned about Standard BioTools Inc (LAB)? - uspostnews.com
Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Purchases 75,000 Shares - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Purchases 125,000 Shares of Stock - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Acquires 150,000 Shares of Stock - MarketBeat
Standard BioTools Inc. Stock (LAB) Opinions on Insider Purchases - Quiver Quantitative
Subdued Growth No Barrier To Standard BioTools Inc. (NASDAQ:LAB) With Shares Advancing 26% - simplywall.st
Will Standard BioTools Inc. stock attract ESG investorsQuarterly Growth Report & High Accuracy Buy Signal Tips - Newser
Why Standard BioTools Inc. (FLB) stock is upgraded to buy2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
Casdin funds buy Standard Biotools (LAB) shares for $502,570 By Investing.com - Investing.com Australia
Casdin funds buy Standard Biotools (LAB) shares for $502,570 - Investing.com
Casdin Capital, LLC Increases Stake in Standard BioTools Inc - GuruFocus
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - MSN
Why Standard BioTools Inc. (FLB) stock is trending on social mediaEarnings Risk Summary & Free High Return Stock Watch Alerts - Newser
How Standard BioTools Inc. (FLB) stock trades in high volatility2025 Market Sentiment & Daily Price Action Insights - Newser
Why analysts raise outlook for Standard BioTools Inc. (FLB) stock2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Weekly Trades: Will Standard BioTools Inc stock attract ESG investorsJuly 2025 Price Swings & AI Driven Stock Movement Reports - BỘ NỘI VỤ
Published on: 2025-12-01 23:56:21 - Newser
BioTools Inc.: A Deep Dive (NASDAQ:LAB) - Seeking Alpha
Penny Stocks To Watch In December 2025 - simplywall.st
Standard BioTools (NASDAQ:LAB) Director Acquires $214,500.00 in Stock - MarketBeat
Casdin Partners Master Fund, L Buys 7,550,000 Shares of Standard BioTools (NASDAQ:LAB) Stock - MarketBeat
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen - MSN
Comparing Pulmonx (NASDAQ:LUNG) and Standard BioTools (NASDAQ:LAB) - Defense World
Aug Intraday: Can Standard BioTools Inc. stock maintain operating marginsWeekly Stock Summary & Weekly Watchlist for Hot Stocks - moha.gov.vn
Standard Biotools Inc Stock (LAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.10%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):